Skip to content

Virginia · Nonprofit

NATIONAL PSORIASIS FOUNDATION

NATIONAL PSORIASIS FOUNDATION (Virginia) receives grants from 143 organizations whose IRS filings report $6,744,801 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($1,404,473). 90 of them have funded it in more than one year, and 66% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$13M
Funders on record
143
Grants received
$6.7M
Net assets
$10.0M
90/143 repeat funderspeak grant-dependency 7%
01What it does

What National Psoriasis Foundation does

Mission

The National Psoriasis Foundation provides people with psoriasis and psoriatic arthritis the services they need to best manage their condition, while promoting research to find a cure.

As stated on its FY2025 Form 990.

Programs

  1. Researchnpf continued to lead collaborative, transformational research by ensuring that funding extramural research remained a priority. In fy 2024, npf invested over $2.9m in research grants and fellowship awards. Introduced in 2020, the npf has invested over $4m towards the psoriasis prevention initiative grant, a study aimed at preventing the onset on cardiovascular disease in people with psoriatic disease, and to provide, timely, adequate treatment for those deemed to be at high risk of developing cardiovascular disease. In fy 2023, the pilot phase of the university of pennsylvania-led study on cvd concluded and planning began for the launch of the full study. This unique, scalable model that tests care coordination across dermatologists and primary care providers saw promising early results in the pilot study. Of the 25% of people in phase one who were identified as having as high risk for cardiovascular disease, 85% followed through with an appointment with their health care provider to address cardiovascular disease. The psa diagnostic test grant was launched in 2020 with the goal of advancing the development of the first diagnostic test for psa, reducing guesswork and long…

    $3,846,872 spentof which $2,930,843 as grants
    40% of program spending
  2. Professional educationnpf continued to expand and strengthen medical education programming targeting health care providers at all levels and stages of career. The 25th annual npf residents' meeting offered dermatology residents the latest in psoriatic disease treatment presented by experts in the field. Npf also launched a complimentary rheumatology fellows meeting to offer education to next generation rheumatologists and develop the relationships between these future care collaborators. The npf hosted its bi-annual npf research symposium: a cure for all, the nation's premier psoriatic disease research event which featured speakers on a wide array of current topics from the psoriasis to psa transition to the results of a novel knockout study aiming to clear psoriasis symptoms with early aggressive biologic treatment.through its dedication to educating health care providers on psoriatic disease and its related diseases, npf has earned accreditation as a provider of continuing medical education. It's part of our efforts to ensure all different types of health care providers understand this complicated disease. Npf offers the psound bytes continuing medical education podcasts,…

    $1,321,080 spent$12,000 earned by the program
    14% of program spending
  3. Advocacynpf continued to advocate on both step therapy and copay accumulator adjustment programs to ensure patients have affordable access to therapies. Npf also leveraged thousands of advocates to work for health insurance coverage improvements for the millions of people living with psoriatic disease, while also working to improve the safety and affordability of psoriasis and psa treatments and increasing federal support for psoriatic disease research.

    $1,063,418 spent
    11% of program spending
  4. Education, outreach, and patient servicesthe npf is proud to have published the first ever psoriasis health indicator report. This set of data about psoriatic disease and its impacts was made possible by a partnership with the centers for disease control and through the contributions of today's leaders in dermatology and rheumatology research and clinical care. The psoriasis health indicator report provides information needed to educate the general public, health officials, and health care providers about key issues and challenges affecting the more than 8 million people in the u.s. Who live with this disease. Since 2016, npf's patient navigation center has supported over 90,000 patients and their caregivers with free, personalized support designed to help them understand psoriatic disease and treatment options, navigate insurance challenges, and find the appropriate health care provider. Npf advance magazine continued to provide the latest information, stories, and resources five times annually for over 25,000 print subscribers and hundreds of thousands of online readers. Each week, more than 283,000 people received advance weekly, the official patient-focused e-newsletter of npf.

    $3,460,775 spent$906,229 earned by the program
    36% of program spending

The 4 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $9,692,145.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($15M) Expenses 100 ($13M) Net assets 100 ($6.8M)2018 Revenue 100 ($15M) Expenses 105 ($13M) Net assets 114 ($7.7M)2019 Revenue 98 ($14M) Expenses 106 ($13M) Net assets 126 ($8.5M)2020 Revenue 98 ($14M) Expenses 110 ($14M) Net assets 129 ($8.7M)2021 Revenue 87 ($13M) Expenses 88 ($11M) Net assets 162 ($11M)2022 Revenue 92 ($13M) Expenses 99 ($13M) Net assets 156 ($11M)2023 Revenue 80 ($12M) Expenses 109 ($14M) Net assets 133 ($9.0M)2024 Revenue 80 ($12M) Expenses 99 ($13M) Net assets 129 ($8.7M)2025 Revenue 87 ($13M) Expenses 93 ($12M) Net assets 147 ($10.0M)
'17'18'19'20'21'22'23'24'25
Revenue (87)Expenses (93)Net assets (147)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $16M to $14M (−13%).

$9.5M
$11M
$12M
$14M
$16M
$14M
$14M
$15M
$15M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2021 7% · 2022 9% · 2023 8% · 2024 3% · 2025 3%. Grants only. Government contracts and fees sit inside program revenue.

84% of NATIONAL PSORIASIS FOUNDATION’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).

This organization
Typical peer · 4,745 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 9 reported years ran a deficit.

$1.8M
’17
$1.2M
’18
$790k
’19
$332k
’20
$1.5M
’21
$852k
’22
−$2.2M
’23
−$991k
’24
$911k
’25
2.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Leah Mccormick Howard

President/CEO

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed232222272426232827
Joined·+4+3+11+1+7+2+11+12
No longer listed·536455613
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 44 funders to 68 funders, grant income rose $363k → $735k.

29 of 143 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 66% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of NATIONAL PSORIASIS FOUNDATION’s funders (the co-funder graph). Top 30 of 143 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

NATIONAL PSORIASIS FOUNDATION has a broad base — no single funder exceeds 21% of grant income, and it takes 4 funders to reach half.

the vertical line marks half of all grant income — 4 funders to its left

71% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NATIONAL PSORIASIS FOUNDATION.

21%
largest funder
47%
top three
~11
effective funders

Largest funder’s share by year: 2017 22% · 2018 24% · 2019 56% · 2020 21% · 2021 21% · 2022 27% · 2023 24% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

52% of NATIONAL PSORIASIS FOUNDATION's funders are still giving 3 years after their first grant; 63% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

66% of NATIONAL PSORIASIS FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $2.3M that is directly attributable, 94% of it comes from funders outside Virginia, across 30 states.

WA
MN
IL
WI
MI
NY
MA
SD
OH
PA
NJ
CT
RI
CA
CO
MO
KY
VA
MD
DE
AZ
TN
NC
DC
OK
LA
AL
GA
TX
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Virginia out of state home

Funder states come from each funder’s own filing. $4.4M arriving through sponsors registered in 16 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

NATIONAL PSORIASIS FOUNDATION runs a healthier operating margin than half of the 2,969 health nonprofits its size.

Operating margin7% · above the median
Months of reserve2.1mo · above the median
Revenue growth (annualized)−2% · bottom quartile

this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025

Organizations like NATIONAL PSORIASIS FOUNDATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Virginia

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

79% of spending goes to programs.

Program 79%Management 11%Fundraising 10%

Governance

19
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

67%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 51 states

AK
ME
VT
NH
WA
ID
MT
ND
MN
IL
WI
MI
NY
MA
OR
NV
WY
SD
IA
IN
OH
PA
NJ
CT
RI
CA
UT
CO
NE
MO
KY
WV
VA
MD
DE
AZ
NM
KS
AR
TN
NC
SC
DC
HI
OK
LA
MS
AL
GA
TX
FL

Screen this organization

A dated, signed PDF of the compliance screen for NATIONAL PSORIASIS FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds NATIONAL PSORIASIS FOUNDATION?
NATIONAL PSORIASIS FOUNDATION (Virginia) receives grants from 143 organizations whose IRS filings report $6,744,801 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($1,404,473). 90 of them have funded it in more than one year, and 66% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does NATIONAL PSORIASIS FOUNDATION have?
IRS filings report 143 organizations giving $6,744,801 in grants to NATIONAL PSORIASIS FOUNDATION, 90 of which have funded it in more than one year.
Who is the largest funder of NATIONAL PSORIASIS FOUNDATION?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $1,404,473 in grants. The full list of funders is on this page.
How can an organization like NATIONAL PSORIASIS FOUNDATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 143 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing